Web Analytics

Taking Aim at Pancreatic Tumors with Immunopeptidomics



Pancreatic cancer is deadly; only about 10% of patents live over five years after they are diagnosed. Patients are typically treated with several options,



Summary

Pancreatic cancer is a devastating disease with a very low five-year survival rate of only 10%. Treatment usually involves a combination of methods tailored to the patient’s specific situation. Due to the complexity and aggressive nature of the cancer, these treatments aim to manage the disease and improve quality of life, but long-term survival remains a significant challenge.

Read more…

This post is part of “Science/Immunology News”, Follow for more…!!!

Dr AF Saeed

Related post

Thank you for Visiting. Leave a Reply!

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.